HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Treatment of Cutaneous Rosai-Dorfman Disease with ALA-PDT Combined with Low-dose Oral Corticosteroids: A Case Report.

Abstract
Cutaneous Rosai-Dorfman Disease (CRDD), a rare form of Rosai-Dorfman Disease (RDD), lacks established treatment guidelines. In this case report, we detailed a successful case of CRDD management in a 50-year-old woman with facial lesions. Our treatment included 5-aminolevulinic acid photodynamic therapy (ALA-PDT) and low-dose oral corticosteroids. Remarkable improvement was evident after six ALA-PDT courses, and a one-year follow-up confirmed sustained remission. This case highlights the potential of combining ALA-PDT with low-dose corticosteroids as a promising therapeutic strategy for CRDD. Further research is necessary to fully elucidate its mechanisms and effectiveness.
AuthorsRunke Zhou, Tingting Wang, Erlong Li, LiLi
JournalPhotodiagnosis and photodynamic therapy (Photodiagnosis Photodyn Ther) Pg. 103914 (Nov 30 2023) ISSN: 1873-1597 [Electronic] Netherlands
PMID38042238 (Publication Type: Case Reports)
CopyrightCopyright © 2023. Published by Elsevier B.V.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: